Ligand validation:3GZD

PLR: (5-HYDROXY-4,6-DIMETHYLPYRIDIN-3-YL)METHYL DIHYDROGEN PHOSPHATE

PLR is a Ligand Of Interest in 3GZD designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3GZD_PLR_C_500	72%	41%	0.117	0.942	0.74	1.52	-	4	2	0	100%	1
3GZD_PLR_A_500	69%	14%	0.144	0.959	1.26	2.55	2	5	3	0	100%	1
3GZD_PLR_B_500	60%	28%	0.142	0.926	0.81	2.05	-	5	2	0	100%	1
3GZD_PLR_D_500	57%	33%	0.141	0.916	0.88	1.74	1	6	1	0	100%	1
3GZC_PLR_A_500	86%	38%	0.107	0.975	0.76	1.63	-	5	1	0	100%	1
2IEG_PLR_A_903	100%	35%	0.029	0.994	1.18	1.38	1	3	9	0	100%	1
2IEI_PLR_B_902	100%	33%	0.034	0.99	1.08	1.56	1	3	6	0	100%	1
3FZ8_PLR_A_500	99%	38%	0.051	0.987	0.98	1.44	-	2	2	0	100%	1
3FSL_PLR_A_500	97%	22%	0.074	0.988	1.43	1.79	2	4	1	0	100%	1
8G9Z_PLR_C_1001	95%	44%	0.077	0.979	1.05	1.12	1	3	3	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.